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Objectives: Studies have demonstrated an association between major depressive disorder (MDD) symp-
toms and fall risk in older adults, which may be at least partially mediated by executive functioning
skills. There have also been observations of increased gait variability associated with fall risk and disease.
This preliminary study first sought to understand whether gait variability in the context of dual task cost
differs among older adults with MDD, relative to those with no history of psychiatric illness, and sec-
ond, to identify relationships between gait variability measures and cognitive functioning in the context
of MDD.
Methods: We recruited 15 older adults with MDD and 17 non-depressed (ND) community-dwelling
older adults. All participants had impaired balance based on unipedal stance time. Assessments included
neuropsychological measures and measures of gait variability using an instrumented gait mat
(GAITRite#) in the context of dual task relative to single task performance (i.e., dual task cost).
Results: The groups did not differ on any gait variability parameters. The MDD group demonstrated
poorer performance in the psychomotor speed domain, relative to the ND group, but cognitive func-
tioning between the groups in other domains was equivalent. In MDD, increased variability in stride
time, stride velocity, and swing time during dual-tasking were associated with poorer executive func-
tioning and visual memory. In ND, no significant relationships between gait variables and cognitive per-
formance were observed.
Conclusions: Findings suggest that unique cognitive mechanisms underlie mobility problems associated
with fall risk in late-life depression. Copyright # 2015 John Wiley & Sons, Ltd.
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Introduction
Increased variability in gait—such as stride-to-stride
fluctuations in length of stride (“stride length”) and
time between steps (“swing time”)—predicts falls in
older adults (Hausdorff et al., 2001), while increased
variability in velocity (“stride velocity”) has been asso-
ciated with neurodegenerative processes such as
Alzheimer’s disease (Nakamura et al., 1996). In other-
wise healthy older adults, history of falls has been
associated with more unsteadiness while walking, with
less consistency and overall poorer gait regulation
(Hausdorff et al., 1997).
Studies of cognitive factors associated with fall risk
have focused on executive functioning (EF), which en-
compasses cognitive abilities used in the efficient ma-
nipulation of information and purposeful behavior
(Lezak et al., 2013). EF moderates the relationship be-
tween physiological function and falls (Rapport et al.,
1998; Herman et al., 2010), likely due to the necessity
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of adequate EF in appropriately regulating and
adjusting movement to limitations and obstacles
(Wright et al., 2011). Poorer EF has been associated
with reduced performance on numerous gait mea-
sures, including those indicative of balance control
while walking and gait speed (Martin et al., 2013), as
well as increased gait variability (Sheridan et al.,
2003), all of which pose an increased risk for falling.
Furthermore, reduced EF has been found to uniquely
predict falls in medical inpatients (Rapport et al.,
1998) and community-dwelling older adults (Herman,
et al., 2005). In their review of the role of EF in gait,
Yogev and colleagues (2008) describe gait as an
“attention-demanding, high-level, controlled task”
that is vulnerable to the burden of additional atten-
tional demands, such as the performance of concur-
rent cognitive or motor tasks (i.e., dual-tasking; DT).
Growing evidence connecting DT with performance
on traditional tests of EF suggest that the former
may be considered a functional analogue of the latter
(Herman et al., 2005; Wright et al., 2011). DT has
been shown to increase gait variability (specifically in
the time between footfalls of the same foot, i.e., “swing
time”) in older adults at risk for falls, and these older
adults performed worse on EF tests than older adults
with no history of falls (Springer et al., 2006).
Depression in late life has been associated with cog-
nitive dysfunction, including deficits in processing
speed, memory, and EF (Lesser et al., 1996; Lockwood
et al., 2002; Baudic et al., 2004; Butters et al., 2004). In
late-life depression, the development of concurrent
executive dysfunction and depressive symptoms may
reflect a shared underlying etiology, such as
frontostriatal pathology (Alexopoulos et al., 2002).
Depression is an independent risk factor for falls in
older adults, with characteristic cognitive deficits likely
contributing to changes in motor coordination and at-
tentional abilities (Iaboni and Flint, 2013). A pilot
study by Wright and colleagues (2011) compared
community-dwelling older adults with major depres-
sive disorder (MDD) to non-depressed (ND) controls
on traditional EF measures as well as on a novel mea-
sure of timed stepping accuracy (i.e., the Walking
Trail-Making Test; W-TMT). Participants with MDD
performed W-TMT-B more slowly than did ND con-
trols and demonstrated a higher DT cost (i.e., DT—
Single Task/Single Task; “DTC”). Additionally, W-
TMT-B performance was significantly correlated with
traditional measures of EF.
Past research suggests, but has not strongly deter-
mined, that gait variability in the context of DT differs
among older adults with MDD, relative to those with
no history of psychiatric illness; however, to date,
most studies investigating this relationship have
measured depression with self-report inventories of
depressive symptoms, and it is unclear how many
individuals in those studies met criteria for MDD. Re-
lationships between gait variability as a function of DT
cost and cognitive functioning (including EF) likely
differ between older adults with and without MDD.
In the present study, we hypothesized that (1) older
adults with MDD would demonstrate more variability
on DT gait measures relative to single task (ST) gait
measures and poorer performance on cognitive mea-
sures; (2) greater gait variability during DT (relative
to ST) would be associated with poorer performance
on cognitive measures, specifically EF (Holtzer et al.,
2014); and (3) relationships among gait variability
and EF would be stronger in the MDD group,
reflecting primary effects of depression on cognition
and gait, as well as possible secondary effects of de-
pression on gait (i.e., via cognitive mechanisms).
Methods
Participants
Participants were 32 women and men ages 61 to
88years [M=73.03, standard deviation (SD)=7.98]
who were recruited from community advertisements,
university research participant registries, and outpa-
tient clinics at University of Michigan. Of these partic-
ipants, 15 had a diagnosis of MDD (nine women and
six men; age M=70.73, SD=7.84) as determined
using the Structured Clinical Interview for DSM-IV
(Spitzer et al., 1994), and 17 had no history of MDD
or any other psychiatric disorders (nine women and
eight men; age M=75.06, SD=7.76). See Table 1 for
further demographic and clinical information.
Exclusion criteria included diagnoses of bipolar de-
pression or psychosis; pre-existing dementia diagnosis;
traumatic brain injury with loss of consciousness
>3min; movement disorders or changes in gait asso-
ciated with parkinsonism, cerebrovascular accident,
epilepsy, or amputation of a lower extremity; current
substance abuse; medical instability (e.g., acute, termi-
nal, or worsening of major medical condition); cur-
rent major medical treatment (e.g., radiation and
chemotherapy); inability to ambulate without an assis-
tive device; severe weight-bearing pain that would
interfere with gait performance; and inability to speak
fluent English.
Participants were included in the study only if they
obtained scores above 24 (out of 30) on the Mini-
mental status exam (Folstein et al., 1975) to rule out
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generalized cognitive impairment and demonstrated
fall risk as measured by a unipedal stance time (UST;
i.e., the duration of time a participant was able to
stand on one foot with eyes open and free movement
of arms) less than 5 s (normal range UST is 30–45 s;
Vellas et al., 1997). High risk of falls was part of the in-
clusion criteria in order to examine gait and cognitive
variables, and the relationships between gait and cog-
nition, among people for whom such relationships
are likely to be most relevant.
Measures
Neuropsychological Measures. Verbal phonemic flu-
ency was measured using the Controlled Oral Word
Association Test (Benton et al., 1994), and semantic
fluency was measured using animal naming (Benton
et al., 1994). For both tests, the total number of ac-
ceptable words served as the score. Trail-Making
Test A and B (Reitan and Reitan, 1985) was admin-
istered to assess motor speed, visual scanning, se-
quencing, and attentional shifting abilities. Time to
completion served as the score for Trail A and was
inverted for ease of interpretation (i.e., less
time=better performance). Trail B requires an
additional attentional shifting component, and the
ratio of time to completion (inverted) for Trail B
to Trail A was derived to provide a measurement
of this set-shifting component while controlling for
psychomotor speed. Verbal learning, recall, and rec-
ognition were measured using the California Verbal
Learning Test—Second Edition (Delis et al., 2000),
a list-learning task of 16 words over five trials
followed by short (1–3min) and long delay (18–
20min) recall trials. A yes-no recognition trial was then
administered. Scoring was completed according to the
manual. Visual learning, recall, and recognition were
assessed using the Brief Visual Memory Test—Revised
(Benedict, 1997), which includes six stimulus figures
presented to participants for 10 s, repeated for three
learning trials, followed by delayed recall (25min)
and recognition trials. Scoring was completed according
to the manual. Manual speed and dexterity were assessed
with the Purdue Pegboard Test (Strauss et al., 2006).
Number of pegs placed in 30s for the right hand, left
hand, and both hands served as performance measures.
Parametric go/no-go stop task. The parametric go/
no-go stop (PGNGS) task measures sustained atten-
tion (go hits) and set-shifting as the task becomes
more difficult; processing speed (go response time),
including simple and subsequently more challenging
conditions of responding with no-go and stop rules;
and inhibitory control, including the ability to stop
an unwanted, prepotent response (correct rejections)
and/or the failure to do so (commissions). The
PGNGS task consists of two separate levels, each with
three conditions, which were completed in order of
ascending difficulty, and are based upon contextual in-
hibition, wherein the target and lure sets change de-
pending upon the context (e.g., previous response).
Table 2 illustrates the conditions in sequential order,
Table 1 Mean and standard deviation of demographic variables by
group
ND MDD
(n = 17) (n = 15)
Mean (SD) Mean (SD)
Age 75 (7.76) 71 (7.84)
Charlson comorbidity index
(age-corrected;
Charlson et al., 1987)
4.33 (1.50) 3.47 (1.25)
Education (years) 16 (2.26) 16 (2.26)
Hamilton Depression Rating Scalea 2.2 (1.70) 17.5 (5.73)
Taking antidepressant(s) (Y/N)b N/A 10/5
Age of depression onsetc N/A 34.6 (20.2)
Note.
at(15.12) =9.6, p< 0.01.
bTwo were treated with duloxetine only, two were treated with
citalopram only, one was treated with mirtazapine only, one was
treated with citalopram and bupropion, one was treated with
citalopram and nortriptyline, one was treated with citalopram and
trazodone, one was treated with fluoxetine and bupropion, and one
was treated with duloxetine, trazodone, and bupropion.
cn = 12, range 10–73, n = 9< age 50 years; n = 30 ≥ age 50 years.
ND, non-depressed; MDD, major depressive disorder; SD, standard
deviation.
Table 2 PGNGS task conditions in sequential order
Condition Targets Rule
Level 1
2 Target go 2 (R and S) Respond to all “R” and
“S” stimuli
2 Target no-go 2 (R and S) Non-repeating, respond
to “R” and “S” in alternation
2 Target stop 2 (R and S) Stop-signal, respond to “R”
and “S” unless interrupted
by a stop sign
Level 2
3 Target go 3 (R, S, and T) Respond to all “R,” “S,”
and “T” stimuli, regardless
of order
3 Target no-go 3 (R, S, and T) Non-repeating, respond to
“R,” “S,” and “T,” not twice
in a row
3 Target stop 3 (R, S, and T) Stop-signal, respond to “R,”
“S,” and “T” unless
interrupted by a stop sign
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by level (number of targets). Accuracy scores for each
set of trials (i.e., go trials, no-go trials, and stop trials)
were derived by dividing the number of correct hits by
the sum of correct hits and errors of commission (i.e.,
hits/hits+errors).
Gait variables. A GAITRite Portable Walkway Sys-
tem# was used to collect and analyze gait variables. This
portable 16 ft long computerized mat is composed of
embedded pressure sensors, which collect gait informa-
tion while the participant walks across it wearing their
own shoes. Variables of interest collected from the
GAITRite# mat include stride time (i.e., time elapsed
in seconds between two consecutive footfalls of the same
foot; associated with gait pace); stride velocity (ratio of
stride length in centimeters/stride time; associated with
gait pace); and swing time (time in seconds between
the last contact with the mat and the next footfall of the
same foot; associated with gait rhythm; Lord et al., 2013).
Procedure
After completing an initial telephone screen, all partic-
ipants signed written informed consent prior to par-
ticipation, as approved by the University of Michigan
and VA Ann Arbor Healthcare System Institutional
Review Boards. A licensed psychologist (S. L.W.) or
trainee under her supervision then administered a
clinical interview including the Hamilton Depression
Rating Scale (Hamilton, 1960) and Structured Clinical
Interview for DSM-IV (Spitzer et al., 1994), as well as
the Mini-mental status exam (Folstein et al., 1975) and
UST (Vellas et al., 1997). Participants who met inclu-
sion criteria were then administered neuropsychologi-
cal and gait assessments on separate days.
A narrowed walkway was created on the
GAITRite# mat specifically for this study, in order
to make the task more challenging (Brown et al.,
2002), consisting of two blue lines of tape spaced
25 cm apart. Participants were instructed to stay be-
tween the lines while performing the tasks. Height,
weight, date of birth, shoe size, sex, and leg length
(measuring from anterior superior iliac spine to lateral
malleolus) were entered into the GAITRite# com-
puter prior to beginning walkway trials.
The battery consisted of three trials each of an ST (i.e.,
walk the length of the mat at normal walking pace, turn
around, and return to starting point) and DT (i.e., walk
the same length of the mat while reciting alternating let-
ters (e.g., a, c, e…) starting with either a or b; or counting
backwards by 2 s, starting at either 95 or 94). All partici-
pants completed the ST trials first. During DT trials, the
participant was asked to pay special attention to correctly
perform the cognitive task, even at the expense of nor-
mal walking speed. The total number of correct re-
sponses and errors during DT was collected. A trial
began when the participant first stepped onto the mat,
was paused briefly when they reached the end of the
mat and turned around, and began again with their first
step onto the mat at return. Timing stopped when their
last foot left the mat. Processing of GAITRite# data was
completed by trained research assistants following a
structured protocol using GAITRite# processing soft-
ware version P4. Data were consolidated and cleaned
via the “GAITRite# Editor” and “Advanced Foot Sepa-
ration” to identify separate footsteps and footfall pattern.
Statistical analyses
Neuropsychological test scores were combined into
domains based on theoretically derived groupings.
Scores on all tests included in domains were standard-
ized to z-scores, using the entire group’s scores, to aid
analysis and interpretation. Specifically, Processing
speed was composed of Trail A and the reaction time
scores for the PGNGS test (i.e., Go trial reaction time
and no-go reaction time). Internal consistency was
improved by excluding stop trial reaction time and
was acceptable (α=0.715). Verbal memory was com-
posed of California Verbal Learning Test short delay
free, short delay cued, long delay free, and long delay
cued recall, and recognition accuracy. This scale dem-
onstrated excellent internal consistency (α=0.96). Vi-
sual Memory was composed of scores on the Brief
Visual Memory subtests total recall, delayed recall,
and recognition. Internal consistency was acceptable
(α=0.74). Psychomotor speed was composed of
Purdue Pegboard number of pegs placed in 30 s for
the right, left, and both hands. Internal consistency
for this scale was good (α=0.85). Because of poor in-
ternal consistency among measures (i.e., α=0.01), an
executive functioning domain was not utilized. Trails
ratio, Controlled Oral Word Association Test, animal
naming, and PGNGS accuracy for six trial types were
analyzed independently, which were theoretically con-
sistent with the proposition that EF encompasses sev-
eral non-uniform cognitive functions (Lezak et al.,
2013), and have been demonstrated to be separable
and to differentially contribute to performance of
higher level cognitive tasks when subjected to factor
analysis (Miyake et al., 2000).
Coefficient of variance (CV) scores for stride time,
swing, time, and stride velocity, respectively, were de-
rived to represent variability in gait performance during
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DT and ST trials by dividing the SD by the mean and
multiplying by 100 [i.e., CV=SD/(M×100)]. ST CV
scores for each gait variable were subtracted from the
DT CV score and divided by the ST CV score (i.e.,
DTST/ST) to create measures of gait variability in
the context of DT cost (i.e., DTC-CV).
Analyses of variance were performed to compare
neuropsychological performance between MDD and
ND groups. Because of non-normal distributions of
gait variability measures, Mann–Whitney U tests of in-
dependent samples were used to test for significant
group differences in these variables. Estimated effect
sizes for Mann–Whitney U tests were calculated using
the following formula: r= z/√n (Field, 2009).
Spearman’s Rho correlations were then used to expli-
cate the relationships among the gait and neuropsy-
chological performance for the entire sample and for
each group separately.
Results
Descriptive statistics, significant analysis of variance
results, and significant Mann–Whitney U results for
gait variables and neuropsychological test scores are
provided in Table 3.
Mann–Whitney U tests demonstrated no significant
group differences in gait variability measures (i.e., DTC-
CV; Table 3). The MDD group made fewer correct re-
sponses during theDT condition, relative to theNDgroup,
but had a similar number of errors. When neuropsycho-
logical performance was compared by group, the MDD
group demonstrated significantly slower performance in
the psychomotor speed domain (median=0.55,
SD=0.81) compared with the ND group (median=0.07,
SD=0.85;U(1, 30)= 44.5, p=0.04; Table 4). No other
significant differences were found.
In the sample as a whole, a significant negative corre-
lation was demonstrated between DTC-CV stride time
and animal naming (rs=0.41, p=0.03) and between
DTC-CV stride time and 2 Target No-Go Accuracy
(rs=0.54, p=0.00). DTC-CV swing time was negatively
correlated with 2 Target No-Go Accuracy (rs=0.47,
p=0.01), and DTC-CV stride velocity was negatively
correlated with 3 Target Stop Accuracy (rs=0.43,
p=0.03; Supporting Information Table S1).
When the sample was split by depression status,
the following significant relationships were found
(Tables 5 and 6). In the MDD group, DTC-CV stride
time was negatively correlated with animal naming
(rs=0.58, p=0.04), 3 Target Go Accuracy
(rs=0.68, p=0.01), and 2 Target No-Go Accuracy
(rs=0.86, p=0.00). DTC-CV swing time was nega-
tively correlated with Trails Ratio (rs=0.53, p=0.04)
and 2 Target No-Go Accuracy (rs=0.77, p=0.00).
DTC-CV stride velocity was negatively correlated with
Visual Memory (rs=0.74, p=0.00). In the ND group,
there were no significant relationships between gait
variability measures and cognitive performance.
Discussion
Findings suggest that among older patients with MDD
at risk of falling, poorer cognitive performance (in the
domains of visual memory and EF) is predictive of
sub-optimal performance on measures of gait variabil-
ity in the context of DT relative to single tasking (i.e.,
swing time, Stride Time, and stride velocity) that have
been linked to fall risk (Hausdorff et al., 2001) and dis-
ease (Blin et al., 1990; Nakamura et al., 1996). In con-
trast, cognitive abilities do not appear to be predictive
of gait variability in the context of DT in ND elders,
also at risk of falling. This preliminary study is the first
Table 3 Means and standard deviations for gait variables of interest, by group
Whole sample ND MDD
(n = 32) (n = 17) (n = 15)
Mean (SD) Mean (SD) Mean (SD) U p r
1. ST stride time (s) 1.2 (0.1) 1.1 (0.1) 1.2 (0.1) 156 0.30 0.19
2. DT stride time (s) 1.4 (0.2) 1.5 (0.3) 1.3 (0.2) 89 0.15 0.26
3. DTC-CV stride time 1.2 (1.3) 1.6 (1.6) 0.7 (0.8) 87 0.13 0.27
4. ST swing time (s) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 140 0.66 0.08
5. DT swing time (s) 0.4 (0.1) 0.5 (0.1) 0.4 (0.1) 88 0.14 0.26
6. DTC-CV swing time 0.7 (1.0) 1.1 (1.2) 0.3 (0.4) 79 0.07 0.32
7. ST stride velocity (cm/s) 103.9 (23.1) 107.6 (28.1) 99.8 (15.6) 109 0.50 0.12
8. DT stride velocity (cm/s) 82.4 (19.3) 79.4 (21.9) 85.7 (16.1) 149 0.43 0.14
9. DTC-CV stride velocity 0.8 (1.1) 1.1 (1.2) 0.5 (0.8) 85 0.11 0.28
10. DT correct responses 9.2 (3.5) 10.6 (3.9) 7.7 (2.3) 72.5 0.04* 0.37
11. DT response errors 1.1 (1.3) 1.3 (1.5) 0.8 (0.2) 100 0.31 0.19
Note: ST, single task; DT, dual task; DTC-CV, dual task cost coefficient of variability; ND, non-depressed; MDD, mild depressive disorder; SD,
standard deviation.
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known study to investigate relationships between gait
variability and cognitive performance among older pa-
tients with MDD, and it strengthens what is known
about the commonly observed triad of gait distur-
bance, depressive symptoms, and cognitive problems
in geriatric patients (Hajjar et al., 2009). Importantly,
it suggests that mechanisms of gait problems may be
different in depressed, relative to ND elders, with cog-
nitive processes contributing to a greater degree in the
former than the latter.
There is a great deal of literature documenting exec-
utive dysfunction and other cognitive difficulties in
older patients with depression, and it is widely believed
that a common mechanism (i.e., disruption to fronto-
striatal-limbic circuitry) may contribute to both classes
of symptoms (Alexopoulos et al., 2002). More recently,
the literature has broadened to include gait disturbance
as a third symptom class that may also have shared eti-
ology (Hajjar et al., 2009; Hsu et al., 2014; Taylor et al.,
2014). The MDD group demonstrated slower perfor-
mances on tests of psychomotor speed compared with
the ND group, which is consistent with previous liter-
ature (Lockwood et al., 2002) and the inclusion of psy-
chomotor retardation symptoms in the diagnostic
criteria for depression (American Psychiatric Associa-
tion, 2014). It was surprising that the MDD and ND
groups did not differ on other cognitive measures, par-
ticularly measures of EF, given the ever-growing litera-
ture supporting this association (Butters et al., 2004). It
is notable that both the MDD and ND participants in
this sample were highly educated, and thus likely have
an elevated level of cognitive reserve (Lenehan et al.,
2015). Cognitive difficulties in the context of
depression may be most evident in samples with a
broader range of premorbid cognitive abilities.
Contrary to expectation, no differences in perfor-
mance were observed between groups on parameters
of gait variability measured under DT relative to ST
conditions. The sample studied consisted entirely of
people at risk for falls, based on UST<5 s (Vellas et
al., 1997), which suggests that both groups exhibit gait
dysfunction, and the effect size for depression status
on gait variability may therefore be small. While the
small sample size of this preliminary study limits our
ability to demonstrate differences in gait variability be-
tween the groups, it is also possible that MDD does
not directly affect gait variability during DT, compared
with the well-demonstrated impact of other neuropsy-
chological syndromes, such as Parkinson’s disease
(Blin et al., 1990). Rather the mechanisms underlying
sub-optimal gait performance may be most relevant
when distinguishing between those with and without
depression at risk of falls. It is especially notable that
the MDD group gave fewer correct responses during
DT conditions, relative to the ND group, suggesting
greater interference on cognitive processes during
DT, in the context of being given explicit instructions
to pay special attention to the cognitive task.
There were a few limitations to consider in making
conclusions about the implications of this study. First,
this is a small sample intended as a preliminary study.
Thus, findings are intended to pave the way for more
directed investigations of mechanisms underlying the
relationship between depression and fall risk in larger
samples. Given that the focus of this study was on cog-
nition and gait variability, there may be other factors
Table 4 Means and standard deviations for cognitive variables of interest, by group
Whole sample ND MDD
(n = 32) (n = 17) (n = 15)
Mean (SD) Mean (SD) Mean (SD) U p r
1. Animal naming (raw score) 18.7 (4.5)a 17.9 (3.8)e 19.7 (5.1)h 117 0.40 0.09
2. COWA (raw score) 40.8 (10.1) 37.9 (9.0) 44.0 (10.5) 177 0.06 0.33
3. Trails ratio (s) 2.4 (1.0)b 2.6 (1.2)f 2.3 (0.6) 124.5 0.86 0.03
4. 2 T go accuracy 0.97 (0.05)a 0.97 (0.04)g 0.96 (0.06)g 105 0.77 0.07
5. 3 T go accuracy 0.95 (0.08)a 0.96 (0.07)g 0.95 (0.08)g 74.5 0.29 0.23
6. 2 T no-go accuracy 0.88 (0.16)a 0.89 (0.15)g 0.87 (0.16)g 94 0.87 0.04
7. 3 T no-go accuracy 0.77 (0.18)c 0.78 (0.13)h 0.75 (0.23)i 84 0.77 0.07
8. 2 T stop accuracy 0.85 (0.18)a 0.88 (0.20)g 0.82 (0.15)g 60.5 0.09 0.33
9. 3 T stop accuracy 0.91 (0.09)c 0.89 (0.11)h 0.92 (0.07)i 81 0.87 0.03
10. Processing speed (z-score) 0.0 (1.0) 0.0 (0.9) 0.1 (1.0) 123 0.88 0.03
11. Verbal memory (z-score) 0.0 (1.0) 0.0 (0.6) 0.0 (1.2) 129 0.97 0.01
12. Visual memory (z-score) 0.0 (1.0)a 0.0 (0.7)e 0.0 (1.0)h 103 0.82 0.05
13. Psychomotor speed (z-score) 0.0 (1.0)d 0.3 (0.8)g 0.3 (0.8)i 44.5 0.04* 0.40
Note: ND, non-depressed; MDD, mild depressive disorder; PGNGS, parametric go/no-go stop; SD, standard deviation; COWA, Controlled Oral
Word Association Test; 2 T, PGNGS 2 target; 3 T, PGNGS 3 target.
*Mean difference significant at p< 0.05.
an = 28, bn = 31, cn = 25, dn = 26, en = 15, fn = 16, gn = 14, hn = 13, in = 12,
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(such as balance deficits) that are more prominent con-
tributors to fall risk and may exacerbate fall risk in ND
older adults in particular. Future studies may therefore
profit from inclusion of additional variables, such as
level daily activity level, and measures specific to the
mechanisms of balance itself. Second, two-thirds of
our depressed participants were using antidepressants
at the time of the study, which have been demonstrated
to increase fall risk (Hartikainen et al., 2007), and may
have impacted the associations among cognitive and
gait variables. Again, a larger sample would allow for
analysis of the potential contribution of antidepressant
use to these relationships. Third, as mentioned previ-
ously, this is a highly educated, primarily Caucasian
sample, and results may not generalize to more hetero-
geneous or less educated samples.
Conclusions
Our findings implicate cognition as a potential target for
interventions to address fall risk in older adults with
late-life depression. The effectiveness of problem-
solving therapy has been demonstrated in depressed
older adults with executive function impairments to re-
duce disability and depression symptoms (Alexopoulos
et al., 2003), although further research is needed tomea-
sure the potential impact of this intervention (or similar
ones) on functional abilities related specifically to gait.
Indeed, multifactorial approaches appear to be the most
appropriate and effective means of preventing falls in at-
risk older adults (Chang et al., 2004), and our results
suggest that future research and interventions for fall
risk (in LLD in particular) should incorporate cognitive
functioning as a target for assessment and treatment
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Key point
• Variability of stride time, stride velocity, and swing
time during DT (relative to single tasking) were
similar in depressed and never-depressed older
adults with balance impairment, but measures of
EF and visual memory were uniquely associated
with gait variability parameters in the context of
DT in the depressed group only. Findings suggest
that unique cognitive mechanisms underlie
mobility problems associated with fall risk in late-
life depression.
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